Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

Qibin Qi, Tsegaselassie Workalemahu, Cuilin Zhang, Frank B. Hu, Lu Qi

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

AimsTo examine the relations between genetic loci, plasma lipoprotein(a) [Lp(a)] levels, and cardiovascular disease (CVD) risk among diabetic patients and compare with the observations in the general population.Methods and resultsIn two prospective cohorts of patients with type 2 diabetes (n=2308) from the Nurses Health Study and the Health Professional Follow-Up Study, we performed (i) genome-wide association (GWA) scans for plasma Lp(a); (ii) prospective analysis of plasma Lp(a) for CVD risk and mortality; and (iii) genetic association analysis for CVD risk and mortality. Meta-analysis of the two GWA scans yielded 71 single-nucleotide polymorphisms (SNPs) on chromosome 6q associated with plasma Lp(a) levels at a genome-wide significance level (P< 5 × 10 -8). The SNP rs10455872 in LPA was most strongly associated with Lp(a) (P=4.60 × 10 -39). Forward-selection analysis indicated that rs10455872 and other five SNPs in a region encompassing LPA, PLG, SLC22A3, and LPAL2 genes were independently associated with Lp(a) levels and jointly explained ∼20 of variation in diabetic patients. In prospective analysis, we did not find any significant association between plasma levels and CVD incidence; the relative risk for coronary heart disease (CHD), CVD, and CVD death was 1.05 [95 confidence interval (CI): 0.951.15], 1.05 (0.961.15), and 1.21 (0.99-1.47) per 1-SD higher log-transformed Lp(a) levels, respectively. Consistently, none of the Lp(a) SNPs were associated with CVD risk or mortality (all P> 0.09). For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95 CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively. The genetic effect on CHD risk showed a significant heterogeneity between the diabetic and the general populations (P=0.006).ConclusionOur data indicate that the effect of Lp(a) on CVD risk among diabetic patients might be different from that in the general population. Diabetes status may attenuate the relation between Lp(a) and cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)325-334
Number of pages10
JournalEuropean Heart Journal
Volume33
Issue number3
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Lipoprotein(a)
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Morbidity
Mortality
Genome-Wide Association Study
Single Nucleotide Polymorphism
Population
Genetic Loci
Health
Meta-Analysis
Chromosomes
Nurses
Genome

Keywords

  • Cardiovascular disease
  • Genome-wide association
  • Lipoprotein(a)
  • Type 2 diabetes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. / Qi, Qibin; Workalemahu, Tsegaselassie; Zhang, Cuilin; Hu, Frank B.; Qi, Lu.

In: European Heart Journal, Vol. 33, No. 3, 02.2012, p. 325-334.

Research output: Contribution to journalArticle

@article{446d85b586794a19bd6cb5008dcb5198,
title = "Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes",
abstract = "AimsTo examine the relations between genetic loci, plasma lipoprotein(a) [Lp(a)] levels, and cardiovascular disease (CVD) risk among diabetic patients and compare with the observations in the general population.Methods and resultsIn two prospective cohorts of patients with type 2 diabetes (n=2308) from the Nurses Health Study and the Health Professional Follow-Up Study, we performed (i) genome-wide association (GWA) scans for plasma Lp(a); (ii) prospective analysis of plasma Lp(a) for CVD risk and mortality; and (iii) genetic association analysis for CVD risk and mortality. Meta-analysis of the two GWA scans yielded 71 single-nucleotide polymorphisms (SNPs) on chromosome 6q associated with plasma Lp(a) levels at a genome-wide significance level (P< 5 × 10 -8). The SNP rs10455872 in LPA was most strongly associated with Lp(a) (P=4.60 × 10 -39). Forward-selection analysis indicated that rs10455872 and other five SNPs in a region encompassing LPA, PLG, SLC22A3, and LPAL2 genes were independently associated with Lp(a) levels and jointly explained ∼20 of variation in diabetic patients. In prospective analysis, we did not find any significant association between plasma levels and CVD incidence; the relative risk for coronary heart disease (CHD), CVD, and CVD death was 1.05 [95 confidence interval (CI): 0.951.15], 1.05 (0.961.15), and 1.21 (0.99-1.47) per 1-SD higher log-transformed Lp(a) levels, respectively. Consistently, none of the Lp(a) SNPs were associated with CVD risk or mortality (all P> 0.09). For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95 CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively. The genetic effect on CHD risk showed a significant heterogeneity between the diabetic and the general populations (P=0.006).ConclusionOur data indicate that the effect of Lp(a) on CVD risk among diabetic patients might be different from that in the general population. Diabetes status may attenuate the relation between Lp(a) and cardiovascular risk.",
keywords = "Cardiovascular disease, Genome-wide association, Lipoprotein(a), Type 2 diabetes",
author = "Qibin Qi and Tsegaselassie Workalemahu and Cuilin Zhang and Hu, {Frank B.} and Lu Qi",
year = "2012",
month = "2",
doi = "10.1093/eurheartj/ehr350",
language = "English (US)",
volume = "33",
pages = "325--334",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

AU - Qi, Qibin

AU - Workalemahu, Tsegaselassie

AU - Zhang, Cuilin

AU - Hu, Frank B.

AU - Qi, Lu

PY - 2012/2

Y1 - 2012/2

N2 - AimsTo examine the relations between genetic loci, plasma lipoprotein(a) [Lp(a)] levels, and cardiovascular disease (CVD) risk among diabetic patients and compare with the observations in the general population.Methods and resultsIn two prospective cohorts of patients with type 2 diabetes (n=2308) from the Nurses Health Study and the Health Professional Follow-Up Study, we performed (i) genome-wide association (GWA) scans for plasma Lp(a); (ii) prospective analysis of plasma Lp(a) for CVD risk and mortality; and (iii) genetic association analysis for CVD risk and mortality. Meta-analysis of the two GWA scans yielded 71 single-nucleotide polymorphisms (SNPs) on chromosome 6q associated with plasma Lp(a) levels at a genome-wide significance level (P< 5 × 10 -8). The SNP rs10455872 in LPA was most strongly associated with Lp(a) (P=4.60 × 10 -39). Forward-selection analysis indicated that rs10455872 and other five SNPs in a region encompassing LPA, PLG, SLC22A3, and LPAL2 genes were independently associated with Lp(a) levels and jointly explained ∼20 of variation in diabetic patients. In prospective analysis, we did not find any significant association between plasma levels and CVD incidence; the relative risk for coronary heart disease (CHD), CVD, and CVD death was 1.05 [95 confidence interval (CI): 0.951.15], 1.05 (0.961.15), and 1.21 (0.99-1.47) per 1-SD higher log-transformed Lp(a) levels, respectively. Consistently, none of the Lp(a) SNPs were associated with CVD risk or mortality (all P> 0.09). For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95 CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively. The genetic effect on CHD risk showed a significant heterogeneity between the diabetic and the general populations (P=0.006).ConclusionOur data indicate that the effect of Lp(a) on CVD risk among diabetic patients might be different from that in the general population. Diabetes status may attenuate the relation between Lp(a) and cardiovascular risk.

AB - AimsTo examine the relations between genetic loci, plasma lipoprotein(a) [Lp(a)] levels, and cardiovascular disease (CVD) risk among diabetic patients and compare with the observations in the general population.Methods and resultsIn two prospective cohorts of patients with type 2 diabetes (n=2308) from the Nurses Health Study and the Health Professional Follow-Up Study, we performed (i) genome-wide association (GWA) scans for plasma Lp(a); (ii) prospective analysis of plasma Lp(a) for CVD risk and mortality; and (iii) genetic association analysis for CVD risk and mortality. Meta-analysis of the two GWA scans yielded 71 single-nucleotide polymorphisms (SNPs) on chromosome 6q associated with plasma Lp(a) levels at a genome-wide significance level (P< 5 × 10 -8). The SNP rs10455872 in LPA was most strongly associated with Lp(a) (P=4.60 × 10 -39). Forward-selection analysis indicated that rs10455872 and other five SNPs in a region encompassing LPA, PLG, SLC22A3, and LPAL2 genes were independently associated with Lp(a) levels and jointly explained ∼20 of variation in diabetic patients. In prospective analysis, we did not find any significant association between plasma levels and CVD incidence; the relative risk for coronary heart disease (CHD), CVD, and CVD death was 1.05 [95 confidence interval (CI): 0.951.15], 1.05 (0.961.15), and 1.21 (0.99-1.47) per 1-SD higher log-transformed Lp(a) levels, respectively. Consistently, none of the Lp(a) SNPs were associated with CVD risk or mortality (all P> 0.09). For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95 CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively. The genetic effect on CHD risk showed a significant heterogeneity between the diabetic and the general populations (P=0.006).ConclusionOur data indicate that the effect of Lp(a) on CVD risk among diabetic patients might be different from that in the general population. Diabetes status may attenuate the relation between Lp(a) and cardiovascular risk.

KW - Cardiovascular disease

KW - Genome-wide association

KW - Lipoprotein(a)

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84863037215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863037215&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehr350

DO - 10.1093/eurheartj/ehr350

M3 - Article

C2 - 21900290

AN - SCOPUS:84863037215

VL - 33

SP - 325

EP - 334

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 3

ER -